This inventor holds 1 USPTO granted patent. Top assignees: Colorado State University Research Foundation, Leland Stanford Junior University, University of California. Active years: 2023.
Company Filing History:
1 out of 488 
1 out of 5,501 
1 out of 15,988 
Years Active: 2023
Title: Innovations by Greg Robertson in Mycobacterial Disease Treatment
Introduction
Greg Robertson is an accomplished inventor based in Fort Collins, CO (US). He has made significant contributions to the field of medical research, particularly in the treatment of mycobacterial diseases. His innovative approach has led to the development of novel methods that enhance the understanding of treatment efficacy.
Latest Patents
Robertson holds a patent titled "Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases." This invention provides novel markers of treatment response in subjects infected with mycobacteria. It allows for quantifying the impact of treatment on the physiological state of the patient. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Throughout his career, Robertson has worked with prestigious institutions such as the University of California and Yale University. His experience in these renowned organizations has contributed to his expertise in evaluating treatment methods for complex diseases.
Collaborations
Robertson has collaborated with notable colleagues, including Gregory Dolganov and Martin Voskuil. These partnerships have further enriched his research and innovation in the field.
Conclusion
Greg Robertson's work in developing methods for evaluating treatment efficacy in mycobacterial diseases highlights his commitment to improving patient outcomes. His contributions to medical research are invaluable and continue to influence the field positively.